Back to News
Market Impact: 0.45

Should Value Investors Buy Universal Health Services (UHS) Stock?

UHS
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesAnalyst Insights
Should Value Investors Buy Universal Health Services (UHS) Stock?

Universal Health Services (UHS) is identified as a compelling value investment, currently holding a Zacks Rank #2 (Buy) and an 'A' Value grade. Its valuation metrics, including a P/E of 9.01 (compared to industry 13.27), a PEG ratio of 0.71 (vs. industry 1.37), and a P/CF of 6.77 (vs. industry 7.44), suggest the stock is likely undervalued relative to its sector. This favorable valuation, combined with a strong earnings outlook, positions UHS as an attractive opportunity for value-oriented portfolios.

Analysis

Universal Health Services (UHS) presents a compelling quantitative profile for value-focused investors, supported by a Zacks Rank #2 (Buy) and a Value grade of 'A'. The company's valuation appears significantly discounted relative to its peers, with a current P/E ratio of 9.01 compared to an industry average of 13.27. This valuation is also near the low end of its 52-week Forward P/E range of 8.03 to 14.67. Furthermore, the PEG ratio of 0.71, which is nearly half the industry average of 1.37, suggests the stock is undervalued relative to its expected earnings growth rate. The company's strong cash generation is highlighted by a Price-to-Cash-Flow (P/CF) ratio of 6.77, below both its industry's average of 7.44 and its own 12-month median of 7.34. The combination of these favorable valuation metrics and a strong earnings outlook, as indicated by the Zacks Rank, suggests that UHS is fundamentally undervalued at its current price.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment